Partner Content Partner Content HPAPI 2020 conference to discuss containment solutions and A... HPAPI Conference
Events Partner Content Highly Potent Active Pharmaceutical Ingredients (HPAPI) SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020.
Partner Content Partner Content The Latest Innovations in HPAPI Manufacturing Technologies HPAPI Technologies
Partner Content Partner Content The need for a blueprint emergency plan to avoid a HPAPI cri... HPAPI Safety Strategies
Partner Content Partner Content Insights into HPAPI Containment and Banding Strategies HPAPI USA Updates
News Jazz gets first FDA nod for HER2 bispecific Ziihera Jazz Pharma has claimed FDA approval for its HER2-directed bispecific antibody Ziihera as a treatment for biliary tract cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends